Mode
Text Size
Log in / Sign up

Atazanavir

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Atazanavir

25 trials tracked of Atazanavir: 18 in phase 3 or 4 and 1 with published results. The most-cited published study has 49 citations.

25Trials tracked
18Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 9 Phase 3 9 Phase 2 1 Phase 1 4 Other / NA 2
  1. Phase 4 Genetics and HIV-1 Protease Inhibitors Completed · 49 cited
  2. Phase 4 Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection Completed
  3. Phase 4 Atazanavir and Lamivudine for Treatment Simplification Completed
  4. Phase 4 Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women Completed
  5. Phase 4 Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients Completed
  6. Phase 4 Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients Completed
Show 19 more trials
  1. Phase 4 Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings Completed
  2. Phase 4 Switch to Unboosted Atazanavir With Tenofovir Study Completed
  3. Phase 4 Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment Completed
  4. Phase 3 Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients Completed
  5. Phase 3 A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) Completed
  6. Phase 3 Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study Completed
  7. Phase 3 Comparative Study of Three NNRTI-Sparing HAART Regimens Completed
  8. Phase 3 Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults Completed
  9. Phase 3 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Completed
  10. Phase 3 Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access Completed
  11. Phase 3 Atazanavir and Endothelial Function in Older HIV Patients Completed
  12. Phase 3 Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults Completed
  13. Phase 2 Study to Evaluate a HIV Drug for the Treatment of HIV Infection Completed
  14. Phase 1 Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants Completed
  15. Phase 1 A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus Completed
  16. Phase 1 Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects Completed
  17. Phase 1 Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat Completed
  18. N/A Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters Completed
  19. N/A Pilot Study of a Raltegravir Based NRTI Sparing Regimen Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.